CN Stock MarketDetailed Quotes

688136 Kexing Biopharm

Watchlist
  • 18.12
  • -0.29-1.58%
Trading Nov 13 14:25 CST
3.62BMarket Cap-30453P/E (TTM)

Kexing Biopharm Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kexing Biopharm Q3 2024 Earnings Date

Currency：CNYOct 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
278.36M
--
-13.02%
Net Income
--
4.29M
--
+152.26%
Analyst Rating
Strong Buy

Nov 13, 2024

Kexing Biopharm Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.949B--
--2024/FY-- / 1.485B--
--2023/FY1.259B / 1.569B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.949B--
--2024/FY-- / 1.485B--
--2023/FY1.259B / 1.569B--
--------
--------

Unlock Free Earnings Estimates

Kexing Biopharm Earnings Reports

  • Third Quarter Report 2024

    Oct 25 12:00 ET

  • Half-year report for the year 2024.

    Aug 19 12:00 ET

  • Summary of Half-Year Report in 2024.

    Aug 19 12:00 ET

  • 2023 ANNUAL REPORT

    Apr 26 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 13, 2024

    Strong Buy

    • Strong Buy

      63.64%

    • Buy

      36.36%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data